ClinicalTrials.Veeva

Menu

Individually Tailored and Integrated Social Support Network for Tobacco Cessation

Lifespan logo

Lifespan

Status

Completed

Conditions

Smoking Cessation

Treatments

Behavioral: Peer Support
Other: Motivational Messages
Behavioral: Text My Quit (TMQ)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03152253
860485-7

Details and patient eligibility

About

This study will continue development of a quit smoking program delivered through text messaging. Upon completion of programming we will enroll 280 participants and randomize them to a control condition or the intervention condition. Assessments will occur at enrollment, and both 3 and 6 month follow ups.

Full description

This study builds on pilot work in which Live Inspired LLC and research partners developed T2Q (formerly "Text-2-Quit") a smoking cessation intervention delivered through text messaging. T2Q is a unique program with a number of features that provide superior support and service compared to existing text message quit smoking products. T2Q is 100% accessible through text messaging provides medication support for quitting smoking, an integrated social support network and live counseling. This phase II project will add functionality to accommodate use of multiple forms of quit smoking medications, and then conduct a rigorous test of the efficacy of T2Q among 280 adult smokers and examine smoking outcomes compared to controls at 3 and 6 months follow up. The study will also examine changes in smoking-related attitudes and behaviors among T2Q users to identify strengths and any potential weaknesses that may affect T2Q's impact on smoking outcomes. Analyses will examine the quality of social interactions within the T2Q integrated social support network and their role in promoting smoking abstinence. We will also conduct interviews with study participants in the T2Q arm to enable understanding of the user's experience with T2Q. Results of this trial will demonstrate the efficacy of T2Q - providing important credibility needed for successful commercialization. This research will also provide important data for possible enhancements to improve consumer appeal prior to commercialization.

This proposal finalizes development and testing of a unique, highly scalable intervention that can reach a U.S. market comprised of over 34 million adult smokers who use text messaging, and provide them with effective, evidence-based treatment. Text messaging enjoys near-market saturation and is a widely preferred method of communication with deep penetration across diverse groups. Wide availability of an attractive and effective smoking cessation program such as T2Q, may exert a powerful, sustained impact on public health

Enrollment

284 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age >18
  • current daily cigarette smoker
  • use of text messaging at least once per week
  • interested in quitting smoking within the next 30 days
  • has access to a physician or healthcare provider
  • no current drug/alcohol abuse.

Exclusion criteria

  • Non-English Speaking
  • Currently using quit-smoking medications or therapies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

284 participants in 2 patient groups, including a placebo group

Text Message for Smoking Cessation
Experimental group
Description:
smoking cessation promotion messages and medication reminders sent via text messages for up to 30 days before quit day and 8 weeks following quit day, along with access to a social support chat room
Treatment:
Behavioral: Text My Quit (TMQ)
Behavioral: Peer Support
Non-Interventional Text Messages
Placebo Comparator group
Description:
General motivational text messages sent on the same schedule at TMQ arm of the study with access to a social support chat room.
Treatment:
Other: Motivational Messages
Behavioral: Peer Support

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems